Aquestive Therapeutics, Inc. Profile Avatar - Palmy Investing

Aquestive Therapeutics, Inc.

Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film f…

Drug Manufacturers - Specialty & Generic
US, Warren [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Aquestive Therapeutics, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of AQST's Analysis
CIK: 1398733 CUSIP: 03843E104 ISIN: US03843E1047 LEI: - UEI: -
Secondary Listings
AQST has no secondary listings inside our databases.